Search
Pixofisiran
go.drugbank.com/drugs/DB17294ExperimentalSynonyms: Rna, (a-g-a-a-g-u-u-g-g-c-a-u-g-g-u-a-g-c-c-c-u-u-g-g-g), complex with rna (c-c-c-a-a-g-g-g-c-u-a-c-c-a-u-g-c-c-a-a-c-u-u-c-u) (1:1)Sultopride
go.drugbank.com/drugs/DB13273ApprovedSultopride is used in Japan, Hong Kong, and Europe to treat schizophrenia. It is of the drug class atypical antipsychotics [L5626].
Indobufen
go.drugbank.com/drugs/DB12545InvestigationalIndobufen has been used in trials studying the supportive care and prevention of Atrial Fibrillation.
Products: INDOBUFENE EGClopidogrel
go.drugbank.com/drugs/DB00758ApprovedInvestigational[A180547] Clopidogrel was granted FDA approval on 17 November 1997.[L7213] … recent MI, stroke, or established peripheral arterial disease,[L7213] It has been shown to be superior to [aspirin] in reducing cardiovascular outcomes in patients with cardiovascular disease and provides
Mixtures: CoPlavix 75/100mg Film-Coated Tablet, CLOPIDOGREL E ACIDO ACETILSALICILICO VIATRISProducts: CLOPIDOGREL EG, CLOPIDOGREL EG STADAProteasome activator complex subunit 1
go.drugbank.com/bio_entities/BE0008976TargetHumansThe PA28 activator complex enhances the generation of class I binding peptides by altering the cleavage pattern of the proteasome
Polypeptides: Proteasome activator complex subunit 1Synonyms: 11S regulator complex subunit alphaTuberous Sclerosis Complex with Subependymal Giant Cell Astrocytoma
go.drugbank.com/conditions/DBCOND0025535Drugs: EverolimusSynonyms: Tuberous Sclerosis Complex with Subependymal Giant Cell AstrocytomaProtein S100-A12
go.drugbank.com/bio_entities/BE0001206TargetHumansS100A12 is a calcium-, zinc- and copper-binding protein which plays a prominent role in the regulation of inflammatory processes and immune response.
Synonyms: EN-RAGEPixantrone
go.drugbank.com/drugs/DB06193ApprovedWithdrawnAnother phase III trial, PIX-R, is now ongoing to clarify pixantrones place in therapy. It will compare pixantrone efficacy to that of gemcitabine. [2] … It is currently being tested in Phase III trials. [2] Although pixantrone has not yet received FDA approval in the United States, it has been granted conditional marketing approval by the European Union